West Pharmaceutical Services, Inc.
WST
Rangering i aksjer
#891
West Pharmaceutical Services, Inc. (WST) specializes in the development,... West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Aksjekurs
$382.91
Markedsverdi
$26.95B
Endring (1 dag)
-0.15%
Endring (1 år)
41.50%
Land
US
Handel West Pharmaceutical Services, Inc. (WST)
Kategori
Healthcare
Driftsmargin for West Pharmaceutical Services, Inc. (WST)
Driftsmargin per October 2026 TTM: 20.64%
Ifølge West Pharmaceutical Services, Inc. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 20.64%. Ved slutten av 2023 hadde selskapet en driftsmargin på 24.09%.
Historikk for driftsmargin for West Pharmaceutical Services, Inc. fra 2000 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2026 (TTM) | 20.64% | 0.39% |
| 2024 | 20.56% | -14.65% |
| 2023 | 24.09% | -8.96% |
| 2022 | 26.46% | -1.27% |
| 2021 | 26.80% | 37.30% |
| 2020 | 19.52% | 21.09% |
| 2019 | 16.12% | 8.70% |
| 2018 | 14.83% | 3.34% |
| 2017 | 14.35% | 0.49% |
| 2016 | 14.28% | 58.84% |
| 2015 | 8.99% | -29.71% |
| 2014 | 12.79% | 11.70% |
| 2013 | 11.45% | 6.22% |
| 2012 | 10.78% | 10.91% |
| 2011 | 9.72% | 1.25% |
| 2010 | 9.60% | -4.38% |
| 2009 | 10.04% | -15.27% |
| 2008 | 11.85% | 6.95% |
| 2007 | 11.08% | -4.24% |
| 2006 | 11.57% | 10.61% |
| 2005 | 10.46% | -11.36% |
| 2004 | 11.80% | 6.21% |
| 2003 | 11.11% | 74.69% |
| 2002 | 6.36% | -38.90% |
| 2001 | 10.41% | 25.42% |
| 2000 | 8.30% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 31.28% | -98.48% |
US
|
|
| 12.36% | -99.40% |
FR
|
|
| 0.00% | - |
JP
|
|
| 9.83% | -99.52% |
US
|
|
| 0.00% | - |
CH
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.